Apolipoprotein C-III amyloidosis in white lions ( Panthera leo )
Veterinary Pathology · 2024
DOI: 10.1177/03009858241230100 ↗Kurz gefasst
Fallbericht in der Zeitschrift Veterinary Pathology, 2024. Verfasst von Natsumi Kobayashi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tokyo University of Agriculture and Technology, Fuchu-shi, Japan. Hauptthemen laut MEDLINE: Amyloidosis, Apolipoprotein C-III, Lions. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science, Program on Open Innovation Platform with Enterprises, Research Institute and Academia.
Abstract (Originalsprache)
Apolipoprotein C-III (ApoC-III) amyloidosis in humans is a hereditary amyloidosis caused by a D25V mutation in the APOC3 gene. This condition has only been reported in a French family and not in animals. We analyzed a 19-year-old white lion ( Panthera leo) that died in a Japanese safari park and found renal amyloidosis characterized by severe deposition confined to the renal corticomedullary border zone. Mass spectrometry-based proteomic analysis identified ApoC-III as a major component of renal amyloid deposits. Amyloid deposits were also positive for ApoC-III by immunohistochemistry. Based on these results, this case was diagnosed as ApoC-III amyloidosis for the first time in nonhuman animals. Five additional white lions were also tested for amyloid deposition retrospectively. ApoC-III amyloid deposition was detected in 3 white lions aged 19 to 21 years but not in 2 cases aged 0.5 and 10 years. Genetic analysis of white and regular-colored lions revealed that the APOC3 sequences of the lions were identical, regardless of amyloid deposition. These results suggest that ApoC-III amyloidosis in lions, unlike in humans, may not be a hereditary condition but an age-related condition. Interestingly, lion ApoC-III has a Val30 substitution compared with other species of Panthera that have Met30. Structural predictions suggest that the conformation of ApoC-III with Met30 and ApoC-III with Val30 are almost identical, but this substitution may alter the ability to bind to lipids. As with the D25V mutation in human ApoC-III, the Val30 substitution in lions may increase the proportion of free ApoC-III, leading to amyloid formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tokyo University of Agriculture and Technology, Fuchu-shi, Japan.
- Okayama University of Science, Imabari-shi, Japan.
ORCID-Profile: Tomoaki Murakami
Förderung
- Japan Society for the Promotion of Science
- Program on Open Innovation Platform with Enterprises, Research Institute and Academia
Zitieren
APA
Kobayashi, N., Iwaide, S., Fukui, H., Une, Y., Itoh, Y., Hisada, M., & Murakami, T. (2024). Apolipoprotein C-III amyloidosis in white lions ( Panthera leo ). Veterinary Pathology. https://doi.org/10.1177/03009858241230100
Vancouver
Kobayashi N, Iwaide S, Fukui H, Une Y, Itoh Y, Hisada M, et al. Apolipoprotein C-III amyloidosis in white lions ( Panthera leo ). Veterinary Pathology. 2024. doi:10.1177/03009858241230100
BibTeX
@article{Kobayashi2024,
author = {Kobayashi, Natsumi and Iwaide, Susumu and Fukui, Hiroto and Une, Yumi and Itoh, Yoshiyuki and Hisada, Miki and Murakami, Tomoaki},
title = {Apolipoprotein C-III amyloidosis in white lions ( Panthera leo )},
journal = {Veterinary Pathology},
year = {2024},
doi = {10.1177/03009858241230100}
}
EUVIMED